Boulder

-48%

est. 2Y upside i

HealthcareSeries C

Rank

#3240

Sector

Digital Health

Est. Liquidity

~3Y

Data Quality

Data: Low

Boulder Care shows strong operational metrics but lacks disclosed valuation and growth data.

Last updated: July 3, 2026

Bull (15%)+50%

Exit multiple holds at 4x on $63.7M revenue, driven by IPO window or category leadership, net after 20% dilution gives ~50% upside.

Base (45%)-35%

Multiple compresses to 2x, converging to public comps, net after 20% dilution results in -35% upside.

Bear (40%)-100%

Multiple collapses to 1x, exit value below $85.7M total funding, common stock recovers -100% due to preference stack.

Est. time to liquidity~2.5 years

Preference Stack Risk

severe

Funding Intensity

57%

Total funding of $85.7M represents ~57% of assumed $150M valuation, creating severe preference overhang.

Dilution Risk

high

With no profitability and likely need for additional capital within 24 months, dilution of 15-25% is expected.

Secondary Liquidity

none

No secondary market activity reported; no current liquidity for employees.

Other — 2 roles

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Boulder's data — designed to show you've done your homework.

1
“How does Boulder plan to defend against incumbent telehealth platforms like Teladoc?”
2
“What are the unit economics and LTV/CAC of your value-based contracts?”
3
“What is the expected timeline to an IPO or acquisition, and how does that affect employee equity liquidity?”

Our model estimates -48% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.